Biote reports first quarter 2024 financial results

Irving, texas--(business wire)--biote (nasdaq: btmd), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the first quarter ended march 31, 2024. first quarter 2024 financial highlights (all financial result comparisons made are against the prior-year period) revenue of $46.8 million, up 4.4% procedure revenue of $37.4 million, up 6.6% gross profit margin of 71.4%, an app.
BTMD Ratings Summary
BTMD Quant Ranking